Neuropathological Alterations in Alzheimer Disease

Serrano-Pozo, A., Frosch, M. P., Masliah, E., Hyman, B. T.·2011·Cold Spring Harbor Perspectives in Medicine

Cited by (1,029)

Items 201–300 of 1,029

  1. Sleep Duration and Subsequent Cortical Thinning in Cognitively Normal Older Adults
    Adam P. Spira, Christopher E. Gonzalez, Vijay K. Venkatraman, Mark N. Wu, Jennifer L. Pacheco, Eleanor Marie Simonsick, Luigi Ferrucci, Susan M. Resnick · 2016 · SLEEP
  2. Role of the peripheral innate immune system in the development of Alzheimer's disease
    Aurélie Y. Le Page, Gilles Dupuis, Eric H. Frost, Anis Larbi, Graham Pawelec, Jacek Maciej Witkowski, Tamàs Fülöp · 2017 · Experimental Gerontology
  3. Alzheimer’s Disease Pathogenesis: Role of Autophagy and Mitophagy Focusing in Microglia
    Eshraghi, Mehdi, Adlimoghaddam, Aida, Mahmoodzadeh, Amir, Sharifzad, Farzaneh, Yasavoli-Sharahi, Hamed, Lorzadeh, Shahrokh, Albensi, Benedict C., Ghavami, Saeid · 2021 · International Journal of Molecular Sciences
  4. Brain somatic mutations observed in Alzheimer’s disease associated with aging and dysregulation of tau phosphorylation
    Park, Jun Sung, Lee, Junehawk, Jung, Eun Sun, Kim, Myeong-Heui, Kim, Il Bin, Son, Hyeonju, Kim, Sangwoo, Kim, Sanghyeon, Park, Young Mok, Mook-Jung, Inhee et al. · 2019 · Nature Communications
  5. Synthesis and Multitarget Biological Profiling of a Novel Family of Rhein Derivatives As Disease-Modifying Anti-Alzheimer Agents
    Elisabet Viayna, Irene Sola, Manuela Bartolini, Angela De Simone, Cheril Tapia‐Rojas, Felipe G. Serrano, Raimon Sabaté, Jordi Juárez‐Jiménez, Belén Pérez, Francisco Javier Luque et al. · 2014 · Journal of Medicinal Chemistry
  6. Passive immunotherapies targeting Aβ and tau in Alzheimer's disease
    Steven Samuel Plotkin, Neil R. Cashman · 2020 · Neurobiology of Disease
  7. Neuroinflammation represents a common theme amongst genetic and environmental risk factors for Alzheimer and Parkinson diseases
    Rachel J. Boyd, Dimitrios Avramopoulos, Lauren L. Jantzie, Andrew S. McCallion · 2022 · Journal of Neuroinflammation
  8. Mechanism involved in insulin resistance via accumulation of β-amyloid and neurofibrillary tangles: link between type 2 diabetes and Alzheimer’s disease
    Sima Kianpour Rad, Aditya Arya, Hamed Karimian, Priya Madhavan, Farzana Rizwan, Shajan Koshy, Girish Prabhu · 2018 · Drug Design Development and Therapy
  9. Is Alzheimer’s Disease Risk Modifiable?
    Alberto Serrano‐Pozo, John H. Growdon · 2019 · Journal of Alzheimer s Disease
  10. Alzheimer’s Disease as a Membrane Disorder: Spatial Cross-Talk Among Beta-Amyloid Peptides, Nicotinic Acetylcholine Receptors and Lipid Rafts
    Camila Fabiani, Silvia S. Antollini · 2019 · Frontiers in Cellular Neuroscience
  11. Amyloid-β-dependent compromise of microvascular structure and function in a model of Alzheimer’s disease
    Adrienne E. Dorr, Bhupinder Sahota, Lakshminarayan V. Chinta, Mary E. Brown, Aaron Y. Lai, Keran Ma, Cheryl A. Hawkes, JoAnne McLaurin, Bojana Stefanovic · 2012 · Brain
  12. Recent advances in the neurobiology and neuropharmacology of Alzheimer’s disease
    Kushal Kumar, Ashwani Kumar, Richard M. Keegan, Rahul R Deshmukh · 2017 · Biomedicine & Pharmacotherapy
  13. A Life-Course Study of Cognitive Reserve in Dementia—From Childhood to Old Age
    Serhiy Dekhtyar, Hui‐Xin Wang, Kirk Scott, Anna Goodman, Ilona Koupil, Agneta Herlitz · 2015 · American Journal of Geriatric Psychiatry
  14. Pathology of the Aging Brain in Domestic and Laboratory Animals, and Animal Models of Human Neurodegenerative Diseases
    Sameh A. Youssef, Maria Tresa Capucchio, Jaime Rofina, James Kenn CHAMBERS, Kazuyuki Uchida, Hiroyuki Nakayama, Elizabeth Head · 2016 · Veterinary Pathology
  15. Exosomes in Alzheimer's disease
    Tarja Malm, Sanna H. Loppi, Katja M. Kanninen · 2016 · Neurochemistry International
  16. Liposomes bi-functionalized with phosphatidic acid and an ApoE-derived peptide affect Aβ aggregation features and cross the blood–brain-barrier: Implications for therapy of Alzheimer disease
    Laura Bana, Stefania Minniti, Elisa Salvati, Silvia Sesana, Vanessa Zambelli, Alfredo Cagnotto, Antonina Orlando, Emanuela Cazzaniga, Rob Zwart, Wiep Scheper et al. · 2013 · Nanomedicine Nanotechnology Biology and Medicine
  17. TNF-α-dependent neuronal necroptosis regulated in Alzheimer's disease by coordination of RIPK1-p62 complex with autophagic UVRAG
    Chong Xu, Jialin Snow Wu, Yiqun Wu, Zhichu Ren, Yuyuan Yao, Guobing Chen, Evandro Fei Fang, Ji Heon Noh, Yong Liu, Libin Wei et al. · 2021 · Theranostics
  18. Spreading of Tau Pathology in Sporadic Alzheimer’s Disease Along Cortico-cortical Top-Down Connections
    Braak, Heiko, Del Tredici, Kelly · 2018 · Cerebral Cortex
  19. Mitochondrial Dysfunction Contributes to the Pathogenesis of Alzheimer’s Disease
    Fabian Cabezas-Opazo, Katiana Vergara-Pulgar, Maria Jose Perez J., Claudia Jara, Cesár Osorio‐Fuentealba, Rodrigo A. Quintanilla · 2015 · Oxidative Medicine and Cellular Longevity
  20. Amyloid β oligomers (AβOs) in Alzheimer’s disease
    Barbara Mroczko, Magdalena Groblewska, Ala Litman‐Zawadzka, Johannes Kornhuber, Piotr Lewczuk · 2017 · Journal of Neural Transmission
  21. Profound degeneration of wake‐promoting neurons in Alzheimer's disease
    Jun Yeop Oh, Rana April Eser, Alexander J. Ehrenberg, Dulce Ovando Morales, Cathrine Petersen, Jessica Kudlacek, Sara Rose Dunlop, Panos Theofilas, Elisa de Paula França Resende, Celica Glenn Cosme et al. · 2019 · Alzheimer s & Dementia
  22. The amyloid plaque proteome in early onset Alzheimer’s disease and Down syndrome
    Drummond, Eleanor, Kavanagh, Tomas, Pires, Geoffrey, Marta-Ariza, Mitchell, Kanshin, Evgeny, Nayak, Shruti, Faustin, Arline, Berdah, Valentin, Ueberheide, Beatrix, Wisniewski, Thomas · 2022 · Acta Neuropathologica Communications
  23. Quaternary Structure Defines a Large Class of Amyloid-β Oligomers Neutralized by Sequestration
    Peng Liu, Miranda N. Reed, Linda Kotilinek, Marianne K. O. Grant, Colleen L. Forster, Wei Qiang, Samantha L. Shapiro, John H. Reichl, Angie C.A. Chiang, Joanna L. Jankowsky et al. · 2015 · Cell Reports
  24. Gold Nanoparticles Treatment Reverses Brain Damage in Alzheimer’s Disease Model
    Natália dos Santos Tramontin, Sabrina da Silva, Rychard Arruda, Kellen Ugioni Simon, Paula Bortoluzzi Canteiro, Gustavo de Bem Silveira, Carolini Mendes, Paulo César Lock Silveira, Alexandre Pastoris Muller · 2019 · Molecular Neurobiology
  25. Liver Dysfunction as a Novel Player in Alzheimer’s Progression: Looking Outside the Brain
    Estrada, Lisbell D., Ahumada, Pablo, Cabrera, Daniel, Arab, Juan P. · 2019 · Frontiers in Aging Neuroscience
  26. Passive Immunization with Phospho-Tau Antibodies Reduces Tau Pathology and Functional Deficits in Two Distinct Mouse Tauopathy Models
    Sethu Sankaranarayanan, Donna M. Barten, Laurel Vana, Nino Devidze, Ling Yang, Gregory W. Cadelina, Nina Hoque, Lynn B. DeCarr, Stefanie Keenan, Alan Lin et al. · 2015 · PLoS ONE
  27. Frequent and symmetric deposition of misfolded tau oligomers within presynaptic and postsynaptic terminals in Alzheimer¿s disease
    Hwan‐Ching Tai, Bo Y. Wang, Alberto Serrano‐Pozo, Matthew P. Frosch, Tara L. Spires‐Jones, Bradley T. Hyman · 2014 · Acta Neuropathologica Communications
  28. EGCG ameliorates high‐fat– and high‐fructose‐induced cognitive defects by regulating the IRS/AKT and ERK/CREB/BDNF signaling pathways in the CNS
    Yashi Mi, Guoyuan Qi, Rong Fan, Qinglian Qiao, Yali Sun, Yu-Qi Gao, Xuebo Liu · 2017 · The FASEB Journal
  29. Copper Toxicity Links to Pathogenesis of Alzheimer’s Disease and Therapeutics Approaches
    Hafza Wajeeha Ijaz, Wei Wang, Minglin Lang · 2020 · International Journal of Molecular Sciences
  30. Why looking at the whole hippocampus is not enough—a critical role for anteroposterior axis, subfield and activation analyses to enhance predictive value of hippocampal changes for Alzheimer’s disease diagnosis
    Aleksandra Maruszak, Sandrine Thuret · 2014 · Frontiers in Cellular Neuroscience
  31. Templated misfolding of Tau by prion-like seeding along neuronal connections impairs neuronal network function and associated behavioral outcomes in Tau transgenic mice
    Stancu, Ilie-Cosmin, Vasconcelos, Bruno, Ris, Laurence, Wang, Peng, Villers, Agnès, Peeraer, Eve, Buist, Arjan, Terwel, Dick, Baatsen, Peter, Oyelami, Tutu et al. · 2015 · Acta Neuropathologica
  32. Stem cell models of Alzheimer’s disease: progress and challenges
    Arber, Charles, Lovejoy, Christopher, Wray, Selina · 2017 · Alzheimer's Research & Therapy
  33. Inadequate supply of vitamins and DHA in the elderly: Implications for brain aging and Alzheimer-type dementia
    Mohajeri, M. Hasan, Troesch, Barbara, Weber, Peter · 2015 · Nutrition
  34. G lycation in P arkinson's disease and Alzheimer's disease
    Hugo Vicente Miranda, Omar M. A. El‐Agnaf, Tiago F. Outeiro · 2016 · Movement Disorders
  35. Specific Signatures of Serum miRNAs as Potential Biomarkers to Discriminate Clinically Similar Neurodegenerative and Vascular-Related Diseases
    Cristina Barbagallo, Giovanni Mostile, Gloriangela Baglieri, Flavia Giunta, Antonina Luca, Loredana Raciti, Mario Zappia, Michele Purrello, Marco Ragusa, Alessandra Susie Quesado Nicoletti · 2019 · Cellular and Molecular Neurobiology
  36. The Relation of the Brain-Derived Neurotrophic Factor with MicroRNAs in Neurodegenerative Diseases and Ischemic Stroke
    Ceren Eyileten, Lucia Sharif, Zofia Wicik, Daniel Jakubik, Joanna Jarosz-Popek, Aleksandra Soplińska, Marek A Postula, Anna Członkowska, Agnieszka Kapłon‐Cieślicka, Dagmara Maria Mirowska-Guzel · 2020 · Molecular Neurobiology
  37. Ocular Neurodegenerative Diseases: Interconnection between Retina and Cortical Areas
    Nicoletta Marchesi, Foroogh Fahmideh, Federica Boschi, Alessia Pascale, Annalisa Barbieri · 2021 · Cells
  38. Flavonoids as Promising Neuroprotectants and Their Therapeutic Potential against Alzheimer’s Disease
    Tarun Minocha, Hareram Birla, Ahmad A. Obaid, Vipin Rai, Sushma Pradeep, Chandan Shivamallu, Mahmoud Moustafa, Mohammed Al-Shehri, Ahmed Al‐Emam, Maria A. Tikhonova et al. · 2022 · Oxidative Medicine and Cellular Longevity
  39. The Role of the JAK/STAT Signaling Pathway in the Pathogenesis of Alzheimer’s Disease: New Potential Treatment Target
    Marta Rusek, Joanna Smith, Kamel El-Khatib, Kennedy Aikins, Stanisław Jerzy Czuczwar, Ryszard M. Pluta · 2023 · International Journal of Molecular Sciences
  40. APOE Stabilization by Exercise Prevents Aging Neurovascular Dysfunction and Complement Induction
    Soto, Ileana, Graham, Leah C., Richter, Hannah J., Simeone, Stephen N., Radell, Jake E., Grabowska, Weronika, Funkhouser, W. Keith, Howell, Megan C., Howell, Gareth R. · 2015 · PLOS Biology
  41. Cardiolipin Profile Changes are Associated to the Early Synaptic Mitochondrial Dysfunction in Alzheimer's Disease
    Vera Filipa Monteiro-Cardoso, Maria Manuel Oliveira, Tânia Melo, M. Rosário Domingues, Paula Isabel Moreira, Elisabete B. Ferreiro, Francisco Peixoto, Romeu António Videira · 2014 · Journal of Alzheimer s Disease
  42. Chitosan as a suitable nanocarrier material for anti-Alzheimer drug delivery
    Jayrajsinh Sarvaiya, Yadvendra Kumar Agrawal · 2014 · International Journal of Biological Macromolecules
  43. Review: Neurodegenerative processes in temporal lobe epilepsy with hippocampal sclerosis: Clinical, pathological and neuroimaging evidence
    Xin You Tai, Boris C. Bernhardt, Maria Thom, Pamela Jane Thompson, Sallie Baxendale, Matthias J. Koepp, Neda Bernasconi · 2017 · Neuropathology and Applied Neurobiology
  44. Therapeutic Potentials of Microalgae in the Treatment of Alzheimer’s Disease
    Tosin Abiola Olasehinde, Ademola Olufolahan Olaniran, Anthony Ifeanyi Okoh · 2017 · Molecules
  45. COVID-19 and Alzheimer’s disease: how one crisis worsens the other
    Xiaohuan Xia, Yi Wang, Jialin Zheng · 2021 · Translational Neurodegeneration
  46. Removing endogenous tau does not prevent tau propagation yet reduces its neurotoxicity
    Wegmann, Susanne, Maury, Eduardo A, Kirk, Molly J, Saqran, Lubna, Roe, Allyson, DeVos, Sarah L, Nicholls, Samantha, Fan, Zhanyun, Takeda, Shuko, Cagsal‐Getkin, Ozge et al. · 2015 · The EMBO Journal
  47. Intracellular Calcium Dysregulation: Implications for Alzheimer’s Disease
    Simona Magi, Pasqualina Castaldo, Maria Loredana Macrì, Marta Maiolino, Alessandra Matteucci, Guendalina Bastioli, Santo Gratteri, Salvatore Amoroso, Vincenzo Lariccia · 2016 · BioMed Research International
  48. Targeting Neuroinflammation as a Therapeutic Strategy for Alzheimer’s Disease: Mechanisms, Drug Candidates, and New Opportunities
    Wing‐Yu Fu, Xiujiao Wang, Nancy Y. Ip · 2018 · ACS Chemical Neuroscience
  49. A Machine Learning Approach for the Differential Diagnosis of Alzheimer and Vascular Dementia Fed by MRI Selected Features
    Castellazzi, Gloria, Cuzzoni, Maria Giovanna, Cotta Ramusino, Matteo, Martinelli, Daniele, Denaro, Federica, Ricciardi, Antonio, Vitali, Paolo, Anzalone, Nicoletta, Bernini, Sara, Palesi, Fulvia et al. · 2020 · Frontiers in Neuroinformatics
  50. Contribution of the Nrf2 Pathway on Oxidative Damage and Mitochondrial Failure in Parkinson and Alzheimer’s Disease
    Francisca Villavicencio-Tejo, Rodrigo A. Quintanilla · 2021 · Antioxidants
  51. Metabolic Risk Factors of Sporadic Alzheimer's Disease: Implications in the Pathology, Pathogenesis and Treatment
    Chakrabarti, Sasanka, Kumar Khemka, Vineet, Banerjee, Anindita, Chatterjee, Gargi, Ganguly, Anirban, Biswas, Atanu · 2015 · Aging and disease
  52. Aged chimpanzees exhibit pathologic hallmarks of Alzheimer's disease
    Melissa K. Edler, Chet C. Sherwood, Richard S. Meindl, William Donald Hopkins, John J. Ely, JOSEPH M. ERWIN, Elliott Jay Mufson, Patrick R. Hof, Mary Ann Raghanti · 2017 · Neurobiology of Aging
  53. Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer’s Disease
    Md. Sahab Uddin, Md. Tanvir Kabir, Kamal Niaz, Philippe Jeandet, Christophe Clément, Bijo Mathew, Abdur Rauf, Kannan R. R. Rengasamy, Eduardo Sobarzo‐Sánchez, Ghulam Md Ashraf et al. · 2020 · Molecules
  54. Glycolytic Metabolism, Brain Resilience, and Alzheimer’s Disease
    Zhang, Xin, Alshakhshir, Nadine, Zhao, Liqin · 2021 · Frontiers in Neuroscience
  55. Cognitive Decline in Preclinical Alzheimer’s Disease: Amyloid-Beta versus Tauopathy
    Colin M. Huber, Connor Yee, Taylor May, Apoorva Dhanala, Cassie S. Mitchell · 2017 · Journal of Alzheimer s Disease
  56. Region-specific depletion of synaptic mitochondria in the brains of patients with Alzheimer’s disease
    Eleanor K. Pickett, Jamie L. Rose, Caoimhe McCrory, Chris-Anne McKenzie, Declan King, Colin Smith, Thomas Henry Gillingwater, Christopher M. Henstridge, Tara L. Spires‐Jones · 2018 · Acta Neuropathologica
  57. Neurotheranostics as Personalized Medicines
    Kevadiya, Bhavesh D., Ottemann, Brendan M., Thomas, Midhun Ben, Mukadam, Insiya, Nigam, Saumya, McMillan, JoEllyn, Gorantla, Santhi, Bronich, Tatiana K., Edagwa, Benson, Gendelman, Howard E. · 2019 · Advanced Drug Delivery Reviews
  58. Small RNA sequencing revealed dysregulated piRNAs in Alzheimer's disease and their probable role in pathogenesis
    Roy, Jyoti, Sarkar, Arijita, Parida, Sibun, Ghosh, Zhumur, Mallick, Bibekanand · 2017 · Molecular BioSystems
  59. Interaction between pathogenic proteins in neurodegenerative disorders
    K. A. Jellinger · 2011 · Journal of Cellular and Molecular Medicine
  60. Olfactory discrimination predicts cognitive decline among community-dwelling older adults
    Hamid Reza Sohrabi, Kristyn Alissa Bates, Michael Weinborn, Amy N.B. Johnston, Amitice Bahramian, Kevin Taddei, Simon Matthew Laws, Mark A. Rodrigues, Michael Morici, M Howard et al. · 2012 · Translational Psychiatry
  61. Tau Antibody Targeting Pathological Species Blocks Neuronal Uptake and Interneuron Propagation of Tau in Vitro
    Nobuhara, Chloe K., DeVos, Sarah L., Commins, Caitlin, Wegmann, Susanne, Moore, Benjamin D., Roe, Allyson D., Costantino, Isabel, Frosch, Matthew P., Pitstick, Rose, Carlson, George A. et al. · 2017 · The American Journal of Pathology
  62. Neuroprotective role of astaxanthin in hippocampal insulin resistance induced by Aβ peptides in animal model of Alzheimer’s disease
    Syed Obaidur Rahman, Bibhu Prasad Panda, Suhel Parvez, Madhu Kaundal, Salman Hussain, Mohd Akhtar, Abul Kalam Najmi · 2018 · Biomedicine & Pharmacotherapy
  63. Blood-brain barrier integrity in the pathogenesis of Alzheimer’s disease
    Zhangsen Huang, Lik‐Wei Wong, Yixun Su, Xiaomin Huang, Nan Wang, Hui Chen, Chenju Yi · 2020 · Frontiers in Neuroendocrinology
  64. In vivo rate-determining steps of tau seed accumulation in Alzheimer’s disease
    Meisl, Georg, Hidari, Eric, Allinson, Kieren, Rittman, Timothy, DeVos, Sarah L., Sanchez, Justin S., Xu, Catherine K., Duff, Karen E., Johnson, Keith A., Rowe, James B. et al. · 2021 · Science Advances
  65. Characterization of the 18 kDa translocator protein (TSPO) expression in post‐mortem normal and Alzheimer's disease brains
    Gui, Yaxing, Marks, Jordan D., Das, Sudeshna, Hyman, Bradley T., Serrano‐Pozo, Alberto · 2020 · Brain Pathology
  66. G-Protein-Coupled Receptors in CNS: A Potential Therapeutic Target for Intervention in Neurodegenerative Disorders and Associated Cognitive Deficits
    Shofiul Azam, Md. Ezazul Haque, Md. Jakaria, Song-Hee Jo, In‐Su Kim, Dong‐Kug Choi · 2020 · Cells
  67. Traditional Chinese Medicine: Role in Reducing β-Amyloid, Apoptosis, Autophagy, Neuroinflammation, Oxidative Stress, and Mitochondrial Dysfunction of Alzheimer’s Disease
    Shi-Yu Chen, Yue Gao, Jiayi Sun, Xianli Meng, Dong Yang, Linhong Fan, Xiang Li, Ping Wang · 2020 · Frontiers in Pharmacology
  68. Genetic architecture of Alzheimer's disease
    Neuner, Sarah M., TCW, Julia, Goate, Alison M. · 2020 · Neurobiology of Disease
  69. ABCA7 and Pathogenic Pathways of Alzheimer’s Disease
    Tomonori Aikawa, Marie‐Louise Holm, Takahisa Kanekiyo · 2018 · Brain Sciences
  70. Analysis of brain sub regions using optimization techniques and deep learning method in Alzheimer disease
    D. Chitradevi, S. Prabha · 2019 · Applied Soft Computing
  71. Cortical atrophy in patients with cerebral amyloid angiopathy: a case-control study
    Fotiadis, Panagiotis, van Rooden, Sanneke, van der Grond, Jeroen, Schultz, Aaron, Martinez-Ramirez, Sergi, Auriel, Eitan, Reijmer, Yael, van Opstal, Anna M, Ayres, Alison, Schwab, Kristin M et al. · 2016 · The Lancet Neurology
  72. From cellular senescence to Alzheimer’s disease: The role of telomere shortening
    Boccardi, Virginia, Pelini, Luca, Ercolani, Sara, Ruggiero, Carmelinda, Mecocci, Patrizia · 2015 · Ageing Research Reviews
  73. Targeting Oxidative Stress Mechanisms to Treat Alzheimer’s and Parkinson’s Disease: A Critical Review
    Aborode, Abdullahi Tunde, Pustake, Manas, Awuah, Wireko Andrew, Alwerdani, Mariam, Shah, Parth, Yarlagadda, Rohan, Ahmad, Shahzaib, Silva Correia, Inês F., Chandra, Ayush, Nansubuga, Esther Patience et al. · 2022 · Oxidative Medicine and Cellular Longevity
  74. Microglia in Alzheimer’s Disease in the Context of Tau Pathology
    Juan Ramón Perea, Marta Bolós, Jesús Ávila · 2020 · Biomolecules
  75. The Role of Vitamins in Neurodegenerative Disease: An Update
    Sachchida Nand, Payal Singh, Harry W.M. Steinbusch, Emanuel Vamanu, Ghulam Md Ashraf, Mohan Prasad Singh · 2021 · Biomedicines
  76. Traumatic brain injury history is associated with an earlier age of dementia onset in autopsy-confirmed Alzheimer’s disease.
    Schaffert, Jeff, LoBue, Christian, White, Charles L., Chiang, Hsueh-Sheng, Didehbani, Nyaz, Lacritz, Laura, Rossetti, Heidi, Dieppa, Marisara, Hart, John, Cullum, C. Munro · 2018 · Neuropsychology
  77. Molecular regulation of dendritic spine dynamics and their potential impact on synaptic plasticity and neurological diseases
    Panchanan Maiti, Jayeeta Manna, G. Ilavazhagan, Julien Rossignol, Gary Leo Dunbar · 2015 · Neuroscience & Biobehavioral Reviews
  78. PPARs in the central nervous system: roles in neurodegeneration and neuroinflammation
    Juan Manuel Zolezzi, Manuel J. Santos, Sussy Bastias Candia, Claudio Pinto, Juan Alejandro Godoy, Nibaldo C. Inestrosa · 2017 · Biological reviews/Biological reviews of the Cambridge Philosophical Society
  79. Multi-Omics Analysis of Microglial Extracellular Vesicles From Human Alzheimer’s Disease Brain Tissue Reveals Disease-Associated Signatures
    Whitaker Cohn, Mikhail Melnik, Calvin Huang, Bruce Teter, Sujyoti Chandra, Chunni Zhu, Laura Beth McIntire, Varghese John, Karen H. Gylys, Tina V. Bilousova · 2021 · Frontiers in Pharmacology
  80. Monoclonal Antibodies against Aβ42 Fibrils Distinguish Multiple Aggregation State Polymorphisms in Vitro and in Alzheimer Disease Brain
    Asa Hatami, Ricardo Albay, Sanaz Monjazeb, Saskia C. F. Milton, Charles G. Glabe · 2014 · Journal of Biological Chemistry
  81. Green synthesized cerium oxide nanoparticle: A prospective drug against oxidative harm
    Debanjan Dutta, Riya Mukherjee, Mousumi Patra, Milon Banik, Rakhi Dasgupta, M. Mukherjee, Tarakdas Basu · 2016 · Colloids and Surfaces B Biointerfaces
  82. Parallel profiling of DNA methylation and hydroxymethylation highlights neuropathology-associated epigenetic variation in Alzheimer’s disease
    Adam R. Smith, Rebecca G. Smith, Ehsan Pishva, Eilis J. Hannon, Janou A. Y. Roubroeks, Joe Burrage, Claire Troakes, Safa Al‐Sarraj, Carolyn Sloan, Jonathan S. Mill et al. · 2019 · Clinical Epigenetics
  83. Future Therapeutic Perspectives into the Alzheimer’s Disease Targeting the Oxidative Stress Hypothesis
    Jéssika Poliana Teixeira, Alexandre Alves de Castro, Flávia V. Soares, Elaine F. F. da Cunha, Teodorico C. Ramalho · 2019 · Molecules
  84. Iatrogenic Creutzfeldt-Jakob disease with Amyloid-β pathology: an international study
    Ignazio Calì, Mark L. Cohen, Stéphane Haı̈k, Piero Parchi, Giorgio Giaccone, Steven John Collins, Diane Kofskey, Han Wang, Catriona McLean, Jean‐Philippe Brandel et al. · 2018 · Acta Neuropathologica Communications
  85. The role of innate immunity in Alzheimer's disease
    Hannah E. Ennerfelt, John R. Lukens · 2020 · Immunological Reviews
  86. Mitochondrial Ca2+ Signaling in Health, Disease and Therapy
    Lorenzo Modesti, Alberto Danese, Veronica Angela Maria Vitto, Daniela Ramaccini, Gianluca Aguiari, Roberta Gafà, Giovanni Lanza, Carlotta Giorgi, Paolo Pinton · 2021 · Cells
  87. Is synaptic loss a unique hallmark of Alzheimer’s disease?
    Scheff, Stephen W., Neltner, Janna H., Nelson, Peter T. · 2014 · Biochemical Pharmacology
  88. Hyperphosphorylated tau mediates neuronal death by inducing necroptosis and inflammation in Alzheimer’s disease
    Yue Dong, Hanqiao Yu, Xueqi Li, Kelong Bian, Yayuan Zheng, Mingrui Dai, Xuejian Feng, Yao Sun, Yu Ting He, Bin Yu et al. · 2022 · Journal of Neuroinflammation
  89. Microglia prevent peripheral immune cell invasion and promote an anti-inflammatory environment in the brain of APP-PS1 transgenic mice
    Michael Stefan Unger, P. Schernthaner, Julia Marschallinger, Heike Mrowetz, Ludwig Aigner · 2018 · Journal of Neuroinflammation
  90. Longitudinal 18F-MK-6240 tau tangles accumulation follows Braak stages
    Tharick Ali Pascoal, Andréa Lessa Benedet, Dana Tudorascu, Joseph Therriault, Sulantha Sanjeewa Mathotaarachchi, Mélissa Savard, Firoza Zubeida Lussier, Cécile Tissot, Mira Chamoun, Min Su Kang et al. · 2021 · Brain
  91. Alzheimer's disease pathology is attenuated in a CD 38‐deficient mouse model
    Blacher, Eran, Dadali, Tulin, Bespalko, Alina, Haupenthal, Viola J., Grimm, Marcus O. W., Hartmann, Tobias, Lund, Frances E., Stein, Reuven, Levy, Ayelet · 2015 · Annals of Neurology
  92. The Many Faces of Astrocytes in Alzheimer's Disease
    Monterey, Michael D., Wei, Haichao, Wu, Xizi, Wu, Jia Qian · 2021 · Frontiers in Neurology
  93. Neurodegeneration and Alzheimer's disease (AD). What Can Proteomics Tell Us About the Alzheimer's Brain?
    Guillermo Moya‐Alvarado, Noga Gershoni‐Emek, Eran Perlson, Francisca C. Bronfman · 2016 · Molecular & Cellular Proteomics
  94. Synaptic Dysfunction in Alzheimer’s Disease: Aβ, Tau, and Epigenetic Alterations
    Ke Li, Qing Wei, Fangfang Liu, Fan Hu, Ao‐Ji Xie, Ling‐Qiang Zhu, Dan Liu · 2017 · Molecular Neurobiology
  95. Cholinesterase Inhibitors for Alzheimer's Disease: Multitargeting Strategy Based on Anti-Alzheimer's Drugs Repositioning
    Md. Tanvir Kabir, Md. Sahab Uddin, Mst. Marium Begum, Shanmugam Thangapandiyan, Md. Sohanur Rahman, Lotfi Aleya, Bijo Mathew, Muniruddin Ahmed, George Emilio Barreto, Ghulam Md Ashraf · 2019 · Current Pharmaceutical Design
  96. Nuclear Factor-Erythroid 2-Related Factor 2 (Nrf2) and Mitochondrial Dynamics/Mitophagy in Neurological Diseases
    Tae‐Cheon Kang · 2020 · Antioxidants
  97. Mitochondrial permeability transition pore: a potential drug target for neurodegeneration
    Komal Kalani, Shi Fang Yan, Shirley ShiDu Yan · 2018 · Drug Discovery Today
  98. Neuropathogenesis-on-chips for neurodegenerative diseases
    Sarnai Amartumur, Huong Mai Nguyen, Thuy Huynh, Testaverde S. Kim, Ran‐Sook Woo, Eungseok Oh, Kyeong Kyu Kim, Luke P. Lee, Chaejeong Heo · 2024 · Nature Communications
  99. Interplay between protein glycosylation pathways in Alzheimer’s disease
    Moran Frenkel‐Pinter, Merav D. Shmueli, Chen Raz, Michaela Yanku, Shai Zilberzwige‐Tal, Ehud Gazit, Daniel Segal · 2017 · Science Advances
  100. Different Force Fields Give Rise to Different Amyloid Aggregation Pathways in Molecular Dynamics Simulations
    Suman Samantray, Feng Yin, Batuhan Kav, Birgit Strodel · 2020 · Journal of Chemical Information and Modeling